EYEG
EyeGate Pharmaceuticals Inc
Price:  
35.30 
USD
Volume:  
34.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EYEG DCF Valuation - Growth Exit 5Y

-1957.2%
Upside

What is the DCF valuation of EYEG??

The Discounted Cash Flow (DCF) valuation of EyeGate Pharmaceuticals Inc (EYEG) is (655.49) USD. With the latest stock price at 35.30 USD, the upside of EyeGate Pharmaceuticals Inc based on DCF is -1957.2%.

Is EYEG a buy or a sell?

Based on the latest price of 35.30 USD and our DCF valuation, EyeGate Pharmaceuticals Inc (EYEG) is a sell. selling EYEG stocks now will result in a potential gain of 1957.2%.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
WACC / Discount Rate 5.2% - 6.9% 6.0%
Long-term Growth Rate 3.0% - 4.9% 4.0%
Fair Price (5,266.83) - (358.20) (655.49)
Upside -15022.3% - -1114.9% -1957.2%
35.30 USD
Stock Price
(655.49) USD
Fair Price